Wealthfront Advisers LLC Bio Rad Laboratories, Inc. Transaction History

Wealthfront Advisers LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$304.11 - $351.99 $39,534 - $45,758	-130 Reduced 9.83%	1,193 $412,000
Q4 2023 Feb 09, 2024	BUY	$269.37 - $365.04 $164,315 - $222,674	610 Added 85.55%	1,323 $427,000
Q3 2023 Nov 01, 2023	BUY	$350.25 - $422.63 $249,728 - $301,335	713 New	713 $255,000
Q1 2023 Apr 28, 2023	BUY	$418.69 - $503.0 $11,723 - $14,084	28 Added 5.03%	585 $280,000
Q4 2022 Feb 10, 2023	SELL	$351.71 - $456.01 $11,254 - $14,592	-32 Reduced 5.43%	557 $234,000
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $160,084 - $218,544	-388 Reduced 39.71%	589 $246,000
Q2 2022 Jul 20, 2022	SELL	$463.67 - $597.16 $196,596 - $253,195	-424 Reduced 30.26%	977 $484,000
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $56,653 - $79,425	108 Added 8.35%	1,401 $789,000
Q4 2021 Jan 21, 2022	SELL	$708.84 - $794.68 $10,632 - $11,920	-15 Reduced 1.15%	1,293 $977,000
Q3 2021 Nov 15, 2021	BUY	$657.71 - $825.77 $15,127 - $18,992	23 Added 1.79%	1,308 $975,000
Q2 2021 Aug 16, 2021	SELL	$576.64 - $649.04 $28,255 - $31,802	-49 Reduced 3.67%	1,285 $828,000
Q1 2021 May 14, 2021	SELL	$547.01 - $662.35 $81,504 - $98,690	-149 Reduced 10.05%	1,334 $762,000
Q4 2020 Feb 16, 2021	BUY	$510.68 - $643.45 $168,524 - $212,338	330 Added 28.62%	1,483 $865,000
Q3 2020 Nov 16, 2020	BUY	$454.43 - $535.6 $293,561 - $345,997	646 Added 127.42%	1,153 $594,000
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $169,779 - $249,981	507 New	507 $229,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Wealthfront Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthfront Advisers LLC with notifications on news.